Top

Journal of Neurology

Published in:

01-11-2014 | Letter to the Editors

X-linked agammaglobulinemia with hearing impairment, dystonia-parkinsonism, and progressive neurodegeneration

Authors: Aloysius Domingo, Thomas G. P. M. Schmidt, Ela Barcelon, Marissa Lukban, Ana Westenberger, Christine Klein

Published in: Journal of Neurology | Issue 11/2014

Excerpt

Dear Sirs, …

Agammaglobulinemia, X-linked, XLA (OMIM#300755). http://omim.org/entry/300755. Accessed 25 Aug 2014

Ziegner UHM, Kobayashi RH, Cunningham-Rundles C et al (2002) Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol 102:19–24. doi:10.1006/clim.2001.5140 CrossRefPubMed

Winkelstein J, Marino M, Lederman H et al (2006) X-Linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 85(4):193–202. doi:10.1097/01.md.0000229482.27398.ad CrossRef

Papapetropoulos S, Friedman J, Blackstone C, Kleiner GI, Bowen BC, Singer C (2007) A progressive, fatal dystonia-parkinsonism syndrome in a patient with primary immunodeficiency receiving chronic IVIG therapy. Mov Disord 22:1664–1666. doi:10.1002/mds.21631 CrossRefPubMed

Vihinen M, Kwan SP, Lester T, Ochs HD, Resnick I, Väliaho J, Conley ME, Smith CI (1999) Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia. Hum Mutat 13(4):280–285. doi:10.1002/(SICI)1098-1004(1999)13:4<280:AID-HUMU3>3.0.CO;2-L CrossRefPubMed

Šedivá A, Smith CIE, Asplund AC et al (2007) Contiguous X-chromosome deletion syndrome encompassing the BTK, TIMM8A, TAF7L, and DRP2 genes. J Clin Immunol 27:640–646. doi:10.1007/s10875-007-9123-x CrossRefPubMed

Velickovic M, Prasad ML, Weston SA, Benson EM (2004) Identification of the bruton tyrosine kinase (BTK) gene mutations in 20 Australian families with X-linked agammaglobulinemia (XLA). Hum Mutat 23:398–399. doi:10.1002/humu.9228 CrossRefPubMed

Tóth B, Volokha A, Mihas A et al (2009) Genetic and demographic features of X-linked agammaglobulinemia in eastern and central Europe: a cohort study. Mol Immunol 46:2140–2146. doi:10.1016/j.molimm.2009.03.012 CrossRefPubMed

Shiroma N, Omi T, Hasegawa H, Nagashima K, Ohta T (2004) A case of X-linked agammaglobulinemia with progressive encephalitis. Pediatr Neurol 31(5):371–373. doi:10.1016/j.pediatrneurol.2004.05.007 CrossRefPubMed

10.

Yang EJ, Yoon JH, Chung KC (2004) Bruton’s tyrosine kinase phosphorylates cAMP-responsive element-binding protein at serine 133 during neuronal differentiation in immortalized hippocampal progenitor cells. J Biol Chem 279:1827–1837. doi:10.1074/jbc.M308722200 CrossRefPubMed

Title: X-linked agammaglobulinemia with hearing impairment, dystonia-parkinsonism, and progressive neurodegeneration
Authors: Aloysius Domingo
Thomas G. P. M. Schmidt
Ela Barcelon
Marissa Lukban
Ana Westenberger
Christine Klein
Publication date: 01-11-2014
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 11/2014
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-014-7483-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

X-linked agammaglobulinemia with hearing impairment, dystonia-parkinsonism, and progressive neurodegeneration

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2014

Inherited disorders of the neuromuscular junction: an update

Non-convulsive status epilepticus after ischemic stroke: a hospital-based stroke cohort study

Rare variant of unknown significance in POLG1 and diagnostic dilemma

Hippocampal damage and affective disorders after treatment of cerebral aneurysms

Late onset hereditary sensory and autonomic neuropathy with cognitive impairment associated with Y163X prion mutation

Deep brain stimulation in Parkinson’s disease: meta-analysis of randomized controlled trials